Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy and safety of Upadacitinib in participants with Takayasu Arteritis (TAK); the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Takayasu Arteritis (TAK) | Phase 3 | Status: ACTIVE_NOT_RECRUITING